AnaptysBio, Inc. (ANAB) Tops Q3 EPS by 56c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q3 EPS of ($1.14), $0.56 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $30.02 million versus the consensus estimate of $6.92 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- What Delta’s report tells investors in American and United
- Trump: Cease Fire Is Over
- Increasing unusual option volume: QFIN IONS ESPR AR CPRX JXN THC PBI IBB KR JACK
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
